This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Zymeworks Bc Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrea Hernandez Rojas: Innovator in Antibody-Drug Conjugates
Introduction
Andrea Hernandez Rojas is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapeutics through his innovative work on antibody-drug conjugates.
Latest Patents
Andrea holds a patent for "Antibody-drug conjugates targeting folate receptor alpha and methods of use." This patent describes antibody-drug conjugates (ADCs) that comprise an antibody construct specifically designed to bind to the human folate receptor alpha (FRα). The ADCs are particularly useful in the treatment of cancer, showcasing Andrea's commitment to advancing medical science.
Career Highlights
Andrea is currently employed at Zymeworks BC Inc., where he continues to develop groundbreaking therapeutic solutions. His work has been instrumental in pushing the boundaries of cancer treatment.
Collaborations
Andrea collaborates with notable colleagues, including James R. Rich and Stuart Daniel Barnscher. These partnerships enhance the innovative environment at Zymeworks BC Inc. and contribute to the success of their projects.
Conclusion
Andrea Hernandez Rojas is a key figure in the development of antibody-drug conjugates, with a focus on improving cancer therapies. His work exemplifies the impact of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile